What contributes more strongly to predicting QOL during 1-year recovery from treatment for clinically localized prostate cancer: 4-weeks-post-treatment depressive symptoms or type of treatment?
What contributes more strongly to predicting QOL during 1-year recovery from treatment for clinically localized prostate cancer: 4-weeks-post-treatment depressive symptoms or type of treatment?
Auteurs
Patrick O. Monahan
Victoria Champion
Susan Rawl
R. Brian Giesler
Barbara Given
Charles W. Given
Debra Burns
Silvia Bigatti
Kristina M. Reuille
Faouzi Azzouz
Jingwei Wu
Michael Koch
